المؤلفون: Arecco, L, Bruzzone, M, Bas, R, Kim, HJ, Di Meglio, A, Bernstein-Molho, R, Hilbers, FS, Pogoda, K, Carrasco, E, Punie, K, Bajpai, J, Agostinetto, E, Lopetegui-Lia, N, Partridge, AH, Phillips, KA, Toss, A, Rousset-Jablonski, C, Curigliano, G, Renaud, T, Ferrari, A, Paluch-Shimon, S, Fruscio, R, Cui, W, Wong, SM, Vernieri, C, Couch, FJ, Dieci, MV, Matikas, A, Rozenblit, M, Aguilar-Y Méndez, D, De Marchis, L, Puglisi, F, Fabi, A, Graff, SL, Witzel, I, Rodriguez Hernandez, A, Fontana, A, Pesce, R, Duchnowska, R, Pais, HL, Sini, V, Sokolović, E, de Azambuja, E, Ceppi, M, Blondeaux, E, Lambertini, M

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology.

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:238908482

المؤلفون: Patel V; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Casimiro S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028 Lisboa, Portugal., Abreu C; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Barroso T; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., de Sousa RT; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Torres S; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Ribeiro LA; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Nogueira-Costa G; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Pais HL; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Pinto C; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Costa L; Pharmacy Department, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal., Costa L; Oncology Division, Unidade Local de Saúde Santa Maria, 1649-028 Lisboa, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

المصدر: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2024; Vol. 5 (3), pp. 678-698. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Open Exploration Country of Publication: United States NLM ID: 101770662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2692-3114 (Electronic) Linking ISSN: 26923114 NLM ISO Abbreviation: Explor Target Antitumor Ther Subsets: PubMed not MEDLINE

المؤلفون: Lobo-Martins S; Department of Medical Oncology, Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Lisbon Instituto de Medicina Molecular-João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon. slmoncology@gmail.com., Pais HL, Soares-de-Almeida L, Costa L, Mansinho A, Teixeira de Sousa R

المصدر: Dermatology online journal [Dermatol Online J] 2021 Jan 15; Vol. 27 (1). Date of Electronic Publication: 2021 Jan 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: University of California, Davis Country of Publication: United States NLM ID: 9610776 Publication Model: Electronic Cited Medium: Internet ISSN: 1087-2108 (Electronic) Linking ISSN: 10872108 NLM ISO Abbreviation: Dermatol Online J Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Melanoma/*drug therapy , Melanoma/*genetics , Proto-Oncogene Proteins B-raf/*antagonists & inhibitors , Proto-Oncogene Proteins B-raf/*genetics , Skin Neoplasms/*drug therapy , Skin Neoplasms/*genetics, Azetidines/therapeutic use ; Back/pathology ; Dacarbazine/therapeutic use ; Humans ; Imidazoles/therapeutic use ; Male ; Melanoma/pathology ; Middle Aged ; Mutation ; Oximes/therapeutic use ; Piperidines/therapeutic use ; Pyridones/therapeutic use ; Pyrimidinones/therapeutic use ; Skin Neoplasms/pathology ; Vemurafenib/therapeutic use

المؤلفون: Marques RP; Faculty of Pharmacy, University of Lisbon, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal. rui.p.marques@chln.min-saude.pt.; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal. rui.p.marques@chln.min-saude.pt., Godinho AR; Centre for Health Evaluation & Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Heudtlass P; Centre for Health Evaluation & Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Pais HL; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Quintela A; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Martins AP; Faculty of Pharmacy, University of Lisbon, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 May; Vol. 146 (5), pp. 1321-1334. Date of Electronic Publication: 2020 Mar 06.

نوع المنشور: Comparative Study; Journal Article; Observational Study

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Bevacizumab/*therapeutic use , Cetuximab/*therapeutic use , Colonic Neoplasms/*drug therapy , Rectal Neoplasms/*drug therapy, Aged ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bevacizumab/administration & dosage ; Cetuximab/administration & dosage ; Cohort Studies ; Colonic Neoplasms/genetics ; Colonic Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Neoplasm Staging ; Proto-Oncogene Proteins p21(ras)/genetics ; Rectal Neoplasms/genetics ; Rectal Neoplasms/pathology ; Retrospective Studies

المؤلفون: Marques RP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal. rui.p.marques@chln.min-saude.pt.; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal. rui.p.marques@chln.min-saude.pt., Heudtlass P; Centre for Health Evaluation and Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Pais HL; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Quintela A; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Martins AP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Jul; Vol. 145 (7), pp. 1719-1728. Date of Electronic Publication: 2019 Apr 29.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bevacizumab/*therapeutic use , Cetuximab/*therapeutic use , Colorectal Neoplasms/*drug therapy, Aged ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/therapeutic use ; Bevacizumab/adverse effects ; Cetuximab/adverse effects ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Patient Reported Outcome Measures ; Prospective Studies ; Quality of Life ; Surveys and Questionnaires

المؤلفون: Marques RP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal; Centro Hospitalar Lisboa Norte - Hospital de Santa Maria, Lisbon, Portugal. Electronic address: rui.p.marques@chln.min-saude.pt., Duarte GS; Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisboa, Portugal; Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal., Sterrantino C; Centre for Reviews and Dissemination, University of York, York, United Kingdom; Department of Clinical and Experimental Medicine, Policlinico 'G. Martino', University of Messina, Messina, Italy., Pais HL; Centro Hospitalar Lisboa Norte - Hospital de Santa Maria, Lisbon, Portugal., Quintela A; Centro Hospitalar Lisboa Norte - Hospital de Santa Maria, Lisbon, Portugal., Martins AP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal., Costa J; Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisboa, Portugal; Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2017 Oct; Vol. 118, pp. 54-62. Date of Electronic Publication: 2017 Aug 25.

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Review; Systematic Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy, Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Colorectal Neoplasms/pathology ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Neoplasm Metastasis ; Organoplatinum Compounds/administration & dosage

SCR Protocol: FOLFOXIRI protocol; Folfox protocol